NBY logo

NovaBay Pharmaceuticals (NBY) Company Overview

Profile

Full Name:

NovaBay Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 26, 2007

Indexes:

Not included

Description:

NovaBay Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative products for eye care and wound care. They specialize in treatments that use their proprietary technology to fight infections and promote healing, aiming to improve patient outcomes in various healthcare settings.

Key Details

Price

$0.58

Annual Revenue

$14.73 M(+2.24% YoY)

Annual EPS

-$138.60(+60.79% YoY)

Annual ROE

-139.03%

Beta

0.03

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Aug 12, 2021

Recent annual earnings:

Mar 25, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 31, 2024

Analyst ratings

Recent major analysts updates

Nov 11, 24 Ascendiant Capital
Buy
Aug 11, 23 Ladenburg Thalmann
Buy
May 20, 22 Ascendiant Capital
Buy
Sep 18, 19 Ladenburg Thalmann
Buy
Mar 13, 19 H.C. Wainwright
Neutral
Mar 26, 18 Roth Capital
Neutral
Jun 5, 17 Roth Capital
Buy
Mar 7, 16 Maxim Group
Hold
Apr 30, 15 Maxim Group
Buy
Mar 6, 13 Ascendiant Capital
Strong Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for NovaBay Pharmaceuticals?
  • Does NovaBay Pharmaceuticals pay dividends?
  • What sector is NovaBay Pharmaceuticals in?
  • What industry is NovaBay Pharmaceuticals in?
  • What country is NovaBay Pharmaceuticals based in?
  • When did NovaBay Pharmaceuticals go public?
  • Is NovaBay Pharmaceuticals in the S&P 500?
  • Is NovaBay Pharmaceuticals in the NASDAQ 100?
  • Is NovaBay Pharmaceuticals in the Dow Jones?
  • When was NovaBay Pharmaceuticals's last earnings report?
  • When does NovaBay Pharmaceuticals report earnings?
  • Should I buy NovaBay Pharmaceuticals stock now?

What is the ticker symbol for NovaBay Pharmaceuticals?

The ticker symbol for NovaBay Pharmaceuticals is NYSE American:NBY

Does NovaBay Pharmaceuticals pay dividends?

No, NovaBay Pharmaceuticals does not pay dividends

What sector is NovaBay Pharmaceuticals in?

NovaBay Pharmaceuticals is in the Healthcare sector

What industry is NovaBay Pharmaceuticals in?

NovaBay Pharmaceuticals is in the Biotechnology industry

What country is NovaBay Pharmaceuticals based in?

NovaBay Pharmaceuticals is headquartered in United States

When did NovaBay Pharmaceuticals go public?

NovaBay Pharmaceuticals's initial public offering (IPO) was on October 26, 2007

Is NovaBay Pharmaceuticals in the S&P 500?

No, NovaBay Pharmaceuticals is not included in the S&P 500 index

Is NovaBay Pharmaceuticals in the NASDAQ 100?

No, NovaBay Pharmaceuticals is not included in the NASDAQ 100 index

Is NovaBay Pharmaceuticals in the Dow Jones?

No, NovaBay Pharmaceuticals is not included in the Dow Jones index

When was NovaBay Pharmaceuticals's last earnings report?

NovaBay Pharmaceuticals's most recent earnings report was on Aug 12, 2021

When does NovaBay Pharmaceuticals report earnings?

The date for NovaBay Pharmaceuticals's next earnings report has not been announced yet

Should I buy NovaBay Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions